Triple-Negative Breast Cancer: A New Clinical Study Opens New and Promising Therapeutic Prospects.

The Research Institute of the McGill University Health Centre will host a new Phase III randomized clinical trial called TROPION-Breast04, as announced by the McPeak-Sirois Group, a provincial consortium of cancer centres across Quebec focused on breast cancer research.